Currencies / INTS
INTS: Intensity Therapeutics Inc
0.28
USD
0.01
(3.45%)
INTS exchange rate has changed by -3.45% for today. During the day, the instrument was traded at a low of 0.28 and at a high of 0.30.
Follow Intensity Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
INTS News
- Benchmark lowers Intensity Therapeutics stock price target to $1.50 on dilution
- Brookline Capital upgrades Intensity Therapeutics stock rating to Buy
- Intensity Therapeutics regains compliance with Nasdaq listing requirements
- Intensity Therapeutics shareholders elect director and approve auditor at annual meeting
- Intensity Therapeutics, Inc. Announces that INT230-6 Achieved 100% Complete Response Rate in Preclinical Models of Malignant Peripheral Nerve Sheath Tumors (MPNST)
- U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.24%
- Morning News Wrap-Up: Thursday’s Biggest Stock Market Stories - TipRanks.com
- Nasdaq Moves Higher; Oracle Shares Jump After Upbeat Q4 Results - CureVac (NASDAQ:CVAC), Helius Medical Tech (NASDAQ:HSDT)
- Dow Tumbles Over 100 Points; US Producer Prices Edge Higher In May - Healthcare Triangle (NASDAQ:HCTI), Greenlane Hldgs (NASDAQ:GNLN)
- Intensity Therapeutics, Inc. Announces Pricing of Public Offering
- Intensity Therapeutics announces public offering of common stock
- Intensity’s cancer drug shows tumor necrosis in early-stage study
- Intensity Therapeutics, Inc.’s Phase 3 INVINCIBLE-3 Sarcoma Study Selected for Presentation at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
- Intensity Therapeutics, Inc. to Collaborate with Author, Model, Executive Producer, Speaker and Breast Cancer Survivor Christine Handy to Raise Patient Awareness of Early-Stage Breast Cancer Treatment
- Intensity Therapeutics stock hits 52-week low at $0.29
- Benchmark maintains Speculative Buy on Intensity Therapeutics stock
- Intensity stock rating cut to Hold by Brookline Capital
- Why Intensity Therapeutics (INTS) Stock Is Getting Hammered - Intensity Therapeutics (NASDAQ:INTS)
- Dow Jumps Over 1,000 Points; Tesla Shares Rise After Q1 Results - Charles & Colvard (NASDAQ:CTHR), AGM Gr Hldgs (NASDAQ:AGMH)
Daily Range
0.28
0.30
Year Range
0.19
4.35
- Previous Close
- 0.29
- Open
- 0.29
- Bid
- 0.28
- Ask
- 0.58
- Low
- 0.28
- High
- 0.30
- Volume
- 934
- Daily Change
- -3.45%
- Month Change
- 3.70%
- 6 Months Change
- -88.03%
- Year Change
- -93.56%
30 August, Saturday